IDA for Onchocerciasis - Trial PACTR201906665550709
Access comprehensive clinical trial information for PACTR201906665550709 through Pure Global AI's free database. This Not Applicable trial is sponsored by Washington University in St. Louis; Case Western Reserve University ; University of Health and Allied Sciences and is currently Not yet recruiting. The study focuses on Infections and Infestations.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Washington University in St. Louis; Case Western Reserve University ; University of Health and Allied Sciences
Bill and Melinda Gates Foundation
Timeline & Enrollment
Not Applicable
Jan 01, 1900
Jan 01, 1900
Summary
This study will provide preliminary data on the safety of IDA treatment in persons with onchocerciasis when it is administered after pre-treatment with IVM to clear or greatly reduce microfilariae from the skin and eyes. Widespread use of IDA following IVM pretreatment (I/IDA) has the potential to greatly accelerate elimination of LF in African countries that are coendemic for LF and onchocerciasis. This study will also assess the efficacy of IDA for killing and sterilizing adult filarial worms. An improved macrofilaricidal treatment would be a major advance for the global program to eliminate onchocerciasis. Since the safety and efficacy objectives are both very important, we have included dual primary objectives for the study.
ICD-10 Classifications
Data Source
Pan Africa Clinical Trials Registry
PACTR201906665550709
Non-Device Trial